NEWARK, Del, July 09, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI), the global fluorescence-guided surgery system market is projected to reach USD 110.8 million in 2024 and USD 468 million by 2034. The market is anticipated to rise at a CAGR of 15.5% from 2024 to 2034.
Increasing surgeries for cancer and cardiovascular diseases are projected to boost the usage of fluorescence-guided surgery systems. The industry is undergoing a rapid digital transformation, leveraging technologies like AI, IoT, and blockchain for enhanced efficiency and personalized customer experiences.
Request A Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-19603
Consumers are prioritizing health and wellness, leading to the rise of functional and nutritious products in the fluorescence-guided surgery system market. Key companies are exploring opportunities in emerging markets, escalating their expertise and resources to expand their presence and tap into new customer segments.
Fluctuations in raw material prices are set to affect profit margins and operational costs, exposing companies in the market to financial risks. Furthermore, changes in consumer preferences are projected to lead to decreased demand for products or services, affecting the market's relevance.
Key Takeaways from the Fluorescence Guided Surgery System Market Report:
- The fluorescence-guided surgery system market is expected to reach a valuation of USD 468 million by 2034.
- The market is projected to surge at a CAGR of 15.5% by 2034.
- China's fluorescence-guided surgery system market is expected to grow at a CAGR of 16.3% by 2034.
- The United States is projected to reach a valuation of USD 84.5 million in 2034.
- Based on type, the SPY system segment held a market share of 34% in 2023.
"Technological advancements and changing consumer preferences are set to fuel expansion in the fluorescence-guided surgery system industry. Leading companies are also projected to benefit from rising demand, favorable regulatory environments, and a growing focus on sustainability." – opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Stay Ahead of the Competition – Download the Full Report Now: https://www.futuremarketinsights.com/checkout/19603
Competitive Landscape:
Leading manufacturers employ strategies such as mergers, acquisitions, partnerships, distribution agreements, collaborations, advertisements, and celebrity endorsements. This helps key companies enhance brand visibility, establish credibility, and gain a competitive advantage in the dynamic landscape.
Leading Fluorescence Guided Surgery System Brands:
- Stryker Corporation
- Hamamatsu Photonics K.K.
- Olympus Corporation
- Medtronic PLC
- OnLume Inc.
- Getinge AB
- Curadel LLC
- PerkinElmer, Inc.
- Karl Storz SE & Co. KG
- Irillic Pvt. Ltd
- Shimadzu Corporation
Industry Updates,
- In 2023, Unify Medical and the Mayo Clinic partnered to develop medical devices using Unify's fluorescence-guided visualization technology.
- In 2024, Leica Microsystems introduced an updated version of its ARveo 8 digital visualization microscope, which enhances surgical visualization in neurosurgery.
Key Segments of Market Report:
By Type:
The industry is segregated into SPY system, PDE system, VS3 iridium system, and others.
By Surgery:
In terms of surgeries, the industry is divided into open surgery and laparoscopy/endoscopy.
By Application:
A few of the important applications include cancer surgeries, cardiovascular surgeries, and others.
By Region:
Key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and the Middle East and Africa are covered.
A Report Preview: https://www.futuremarketinsights.com/reports/fluorescence-guided-surgery-system-market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage in the Healthcare Market Insights Domain:
The global nonvascular interventional radiology device market size is likely to adhere to a CAGR of 4.9%. The ecosystem is likely to get elevated from USD 27.6 billion in 2024 to the valuation mark of USD 44.6 billion by 2034.
The global next-generation titrator market share is expected to reach USD 7,171.9 million by 2034, owing to a moderate CAGR of 6.5% through the forecast period. The competitive space was measured at USD 3,820.6 million in 2024.
The global pressure infusion cuffs market demand is estimated to ascend at a valuation of approximately USD 350.8 million by 2024 as per Future Market Insights report. The change in industry valuation for the pressure infusion cuffs is likely to be at a moderate CAGR of 5.7% through 2034. The change in value in the ecosystem is estimated to reach a value of USD 610.7 million by the end of the forecast period.
The global venous stents market strategies valued at approximately USD 990.5 million in 2023, is expected to soar to an impressive USD 2.2 billion by the end of 2033. This growth represents a substantial compound annual growth rate (CAGR) of 8.4% from 2023 to 2033.
The global intravenous pegloticase market trends with a slowly progressing CAGR of 13.8% from 2023 to 2033, this market is expected to garner USD 3.19 Billion by 2023 and USD 11.61 Billion by 2033.
The projected global photoacoustic microscopy market opportunity is likely to hit the USD 120 billion valuation mark by 2024. Owing to an impressive CAGR of 17.3% through 2034, the ecosystem is set to reach USD 591.6 million by the end of the forecast period.
The global peripheral intravenous catheter market growth is expected to surpass USD 13,006.1 million by 2034, up from USD 6,489.3 million in 2024. A significant trend is the introduction of closed catheters for injecting tracers during computed tomography. The projected CAGR of 7.2%.
The global endovenous laser therapy market outlook was valued at USD 378.3 Million in 2021 and is expected to reach USD 811.0 Million by 2031
The global arteriovenous fistula treatment market development is projected to amass revenue of about USD 1,356.5 million by 2033. The overall market value is expected to be worth USD 765.8 million in 2023. The worldwide adoption of arteriovenous fistula treatment is projected to advance at a CAGR of 5.9%.
The global intravenous iron drugs market forecast is projected to reach USD 2.8 Billion in 2022 and is expected to grow to USD 6.3 Billion by 2032 at a CAGR of 8.5%.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
